Warmest Wishes for 2021
As our community knows, the COVID-19 pandemic greatly affected all aspects of breast cancer care, including clinical trials. Yet, with your support, we have been...
Read MoreWhen to Use Surgery & Radiation to the Breast
Headlines announcing the phase III clinical trial (ECOG-ACRIN 2108) results stated that radiation and surgery to the breast–also called locoregional therapy...
Read MoreMetastatic Trial Search: New & Improved
Metastatic Trial Search has been re-designed and updated. We’ve provided more personalized matching by adding: New biomarkers: PD-L1, Androgen...
Read MoreBody Image and Metastatic Breast Cancer
Research shows that changes to the body caused by metastatic cancer or treatments for metastatic cancer can affect a person’s body image. Body image is how...
Read MoreGiving the Right Dose of Drugs for MBC: The Patient-Centered Dosing Initiative and Project Optimus
The Patient-Centered Dosing Initiative was started by MBC patient advocates, Anne Loeser and Julia Maués. This movement seeks to educate patients, doctors, and...
Read MoreFDA Approves Keytruda®
On November 13, 2020, the FDA approved pembrolizumab (Keytruda®) in combination with chemotherapy for the treatment of patients with locally recurrent...
Read MoreCreativity to Cope with MBC
If you are diagnosed with MBC, you may live with the disease for years. The stress of treatment side effects, cancer symptoms, uncertainty, and fear can have a...
Read MoreHER2-Low Expressing: A New Subcategory of HER2-Negative Breast Cancer?
Under current treatment guidelines, breast cancer is categorized as HER2-positive or HER2-negative. However, some investigators use the term HER2-low expressing...
Read MoreHow to Prepare for a Virtual SABCS
The San Antonio Breast Cancer Symposium (SABCS) is an important annual breast cancer conference. Last year, SABCS offered more than 1,700 breast cancer-related...
Read MoreSEARCH OUR SITE
for past articles or specific information.